ACCUPRO

Brand name authorized in: Austria Germany Finland Ireland Lithuania Poland United Kingdom

Active ingredients

The drug ACCUPRO contains one active pharmaceutical ingredient (API):

1 Quinapril
UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Read about Quinapril

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Quinapril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 03738798, 03738829, 11856224
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 410316, 410738
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 14360, 14392, 14401, 14406
IE
Health Products Regulatory Authority
Identifier(s): 10077, 10251, 10278, 10294
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1003701, 1003702, 1003703, 1004175, 1004176, 1004307, 1005359, 1016299
PL
Rejestru Produktów Leczniczych
Identifier(s): 100074870, 100074886, 100074892, 100125230, 100324716, 100324722, 100324739